CVS Group Plc, a leading provider of integrated veterinary services in the UK, announced the exercise of options over a total of 6,126 ordinary shares of 0.2 pence each. The options were exercised under the CVS Group 2020 SAYE Plan at an exercise price of £10.09. The issuance of shares in connection with the exercise was fully satisfied by shares held by the CVS Group Employee Benefit Trust. Following the exercise, a total of 645 Ordinary Shares are held by the EBT, representing approximately 0.001% of the Company's total voting rights.
Ben Jacklin, Deputy CEO, exercised options over 570 Ordinary Shares in the Company. Following this exercise, Ben Jacklin holds a beneficial interest in 37,284 Ordinary Shares in the Company, representing approximately 0.052% of the total voting rights of the Company.
The notification also includes details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor, as well as the details of the transaction, including the financial instrument, nature of the transaction, price, volume, date, and place of the transaction.
For further information, the company can be contacted through the provided contacts, including CVS Group plc, Peel Hunt LLP, Berenberg, and Camarco.
This announcement provides insight into the exercise of options and PDMR dealing within CVS Group Plc, offering transparency and compliance with the UK Market Abuse Regulation.